- 全部删除
您的购物车当前为空
Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate that utilizes Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker.

Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate that utilizes Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 3,090 | 待询 | |
| 5 mg | ¥ 8,150 | 待询 | |
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Mal-(CH2)5-Val-Cit-PAB-Eribulin 相关产品
| 产品描述 | Mal-(CH2)5-Val-Cit-PAB-Eribulin is a potent antitumor ADC drug-linker conjugate that utilizes Eribulin, an anti-microtubule agent, connected through the Mal-(CH2)5-Val-Cit-PAB linker. |
| 体外活性 | Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules[2]. |
| 别名 | Mal-(CH2)5-Val-Cit-PAB-Eribulin |
| 分子量 | 1328.565 |
| 分子式 | C69H97N7O19 |
| CAS No. | 2130869-21-3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容